Suppressors of cytokine signaling and immunity (original) (raw)

• Nicola, N.A. (ed.) Guidebook to Cytokines and Their Receptors (Oxford University Press, Oxford, 1994).
  Google Scholar
• Ihle, J.N. Cytokine receptor signalling. Nature 377, 591–594 (1995).
  Article CAS Google Scholar
• O'Shea, J.J., Gadina, M. & Schreiber, R.D. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell. 109, S121–131 (2002).
  Article CAS Google Scholar
• Yasukawa, H., Sasaki A. & Yoshimura A. Negative regulation of cytokine signaling pathways. Annu. Rev. Immunol. 18, 143–164 (2000).
  Article CAS Google Scholar
• Alexander, W.S. Suppressors of cytokine signalling (SOCS) in the immune system. Nat. Rev. Immunol. 2, 410–416 (2002).
  Article CAS Google Scholar
• Greenhalgh, C.J., Miller, M.E., Hilton, D.J. & Lund, P.K. Suppressors of cytokine signaling: relevance to gastrointestinal function and disease. Gastroenterology 123, 2064–2081 (2002).
  Article CAS Google Scholar
• Naka, T. et al. Structure and function of a new STAT-induced STAT inhibitor. Nature 387, 924–929 (1997).
  Article CAS Google Scholar
• Starr, R. et al. A family of cytokine-inducible inhibitors of signalling. Nature 387, 917–921 (1997).
  Article CAS Google Scholar
• Endo, T.A. et al. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387, 921–924 (1997).
  Article CAS Google Scholar
• Yoshimura, A. et al. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J. 14: 2816–2826 (1995).
  Article CAS Google Scholar
• Ram, P.A. & Waxman, D.J. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J. Biol. Chem. 274, 35553–35561 (1999).
  Article CAS Google Scholar
• Favre, H., Benhamou, A., Finidori, J., Kelly, P.A. & Edery, M. Dual effects of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction. FEBS Lett.; 453: 63–66 (1999).
  Article CAS Google Scholar
• Greenhalgh, C.J. et al. Biological evidence that SOCS-2 can act either as an enhancer or suppressor of growth hormone signaling. J. Biol. Chem. 277, 40181–40184 (2002).
  Article CAS Google Scholar
• Greenhalgh, C.J. et al. Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b). Mol. Endocrinol. 16, 1394–1406 (2002).
  Article CAS Google Scholar
• Metcalf, D. et al. Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 405, 1069–1073 (2000).
  Article CAS Google Scholar
• Seki, Y. et al. Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation. Proc. Natl. Acad. Sci. USA 99, 13003–13008 (2002).
  Article CAS Google Scholar
• Yasukawa, H. et al. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18, 1309–1320 (1999).
  Article CAS Google Scholar
• Giordanetto, F. & Kroemer, R.T. A three-dimensional model of suppressor of cytokine signalling 1 (SOCS-1). Protein Eng. 16, 115–124 (2003).
  Article CAS Google Scholar
• Sasaki, A. et al. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2. J. Biol. Chem. 275, 29338–29347 (2000).
  Article CAS Google Scholar
• Nicholson, S.E. et al. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc. Natl Acad. Sci. USA 97, 6493–6498 (2000).
  Article CAS Google Scholar
• Lehmann, U. et al. SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130. J. Biol. Chem. 278, 661–671 (2003).
  Article CAS Google Scholar
• Hortner, M., Nielsch, U., Mayr, L.M., Heinrich, P.C. & Haan, S. A new high affinity binding site for suppressor of cytokine signaling-3 on the erythropoietin receptor. Eur. J. Biochem. 269, 2516–2526 (2002).
  Article CAS Google Scholar
• Bjorbaek, C. et al. SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J. Biol. Chem. 275, 40649–40657 (2000).
  Article CAS Google Scholar
• De Souza, D. et al. SH2 domains from suppressor of cytokine signaling-3 and protein tyrosine phosphatase SHP-2 have similar binding specificities. Biochemistry 41, 9229–9236 (2002).
  Article CAS Google Scholar
• Kamura, T. et al. The elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat and ankyrin repeat families. Genes Dev. 12, 3872–3881 (1998).
  Article CAS Google Scholar
• Zhang, J.G. et al. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc. Natl. Acad. Sci. USA 96, 2071–2076 (1999).
  Article CAS Google Scholar
• Kamizono, S. et al. The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J. Biol. Chem. 276, 12530–12538 (2001).
  Article CAS Google Scholar
• Frantsve, J., Schwaller, J., Sternberg, D.W., Kutok, J. & Gilliland, D.G. Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation. Mol. Cell. Biol. 21, 3547–3557 (2001).
  Article CAS Google Scholar
• Zhang, J.G. et al. The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo. Proc. Natl. Acad. Sci. USA 98, 13261–13265 (2001).
  Article CAS Google Scholar
• Haan, S. et al. Tyrosine phosphorylation disrupts elongin interaction and accelerates SOCS3 degradation. J. Biol. Chem. 278, 31972–31979 (2003).
  Article CAS Google Scholar
• Naka, T. et al. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1)-deficient mice. Proc. Natl. Acad. Sci. USA 95, 15577–15582 (1998).
  Article CAS Google Scholar
• Starr, R. et al. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sci. USA 95, 14395–14399 (1998).
  Article CAS Google Scholar
• Marine, J.C. et al. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 98, 609–616 (1999).
  Article CAS Google Scholar
• Alexander, W.S. et al. SOCS1 is a critical inhibitor of interferon-signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98, 597–608 (1999).
  Article CAS Google Scholar
• Bullen, D.V., Darwiche, R., Metcalf, D., Handman, E. & Alexander, W.S. Neutralization of interferon- in neonatal SOCS1 −/− mice prevents fatty degeneration of the liver but not subsequent fatal inflammatory disease. Immunology 104, 92–98 (2001).
  Article CAS Google Scholar
• Metcalf, D. et al. Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppressor of cytokine signaling-1 (SOCS-1). Proc. Natl. Acad. Sci. USA 99, 943–948 (2002).
  Article CAS Google Scholar
• Hanada, T. et al. Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity. Immunity 19, 437–450 (2003).
  Article CAS Google Scholar
• Sporri, B., Kovanen, P.E., Sasaki, A., Yoshimura, A. & Leonard, W.J. JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling. Blood 97, 221–226 (2001).
  Article CAS Google Scholar
• Cornish, A.L. et al. Suppressor of cytokine signaling-1 regulates signaling in response to interleukin-2 and other γ c-dependent cytokines in peripheral T cells. J. Biol. Chem. 278, 22755–22761 (2003).
  Article CAS Google Scholar
• Diehl, S. et al. Inhibition of TH1 differentiation by IL-6 is mediated by SOCS1. Immunity 13, 805–815 (2000).
  Article CAS Google Scholar
• Eyles, J.L., Metcalf, D., Grusby, M.J., Hilton, D.J. & Starr, R. Negative regulation of interleukin-12 signaling by suppressor of cytokine signaling-1. J. Biol. Chem. 277, 43735–43740 (2002).
  Article CAS Google Scholar
• Ilangumaran, S., Ramanathan, S., La Rose, J., Poussier, P. & Rottapel, R. Suppressor of cytokine signaling 1 regulates IL-15 receptor signaling in CD8+CD44high memory T lymphocytes. J. Immunol. 171, 2435–2445 (2003).
  Article CAS Google Scholar
• Ilangumaran, S. et al. Suppressor of cytokine signaling 1 attenuates IL-15 receptor signaling in CD8+ thymocytes. Blood prepublished online, 7 August 2003 (doi:10.1182/blood-2003-01-0175).
• Morita, Y. et al. Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor-necrosis-factor—induced cell death in fibroblasts. Proc. Natl. Acad. Sci. USA 97, 5405–5410 (2000).
  Article CAS Google Scholar
• Kinjyo, I. et al. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17, 583–591 (2002).
  Article CAS Google Scholar
• Nakagawa, R. et al. SOCS-1 participates in negative regulation of LPS responses. Immunity 17, 677–687 (2002).
  Article CAS Google Scholar
• Kawazoe, Y. et al. Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation. J. Exp. Med. 193, 263–269 (2001).
  Article CAS Google Scholar
• De Sepulveda, P. et al. Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation. EMBO J. 18, 904–915 (1999).
  Article CAS Google Scholar
• Naka, T. et al. SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN- and IL-4 signaling in vivo. Immunity 14, 535–545 (2001).
  Article CAS Google Scholar
• Metcalf, D., Mifsud, S., Di Rago, L. & Alexander, W.S. The lethal effects of transplantation of Socs1 −/− bone marrow cells into irradiated adult syngeneic recipients Proc. Natl. Acad. Sci. USA 100, 8436–8441 (2003).
  Article CAS Google Scholar
• Chong, M.M. et al. Suppressor of cytokine signaling-1 is a critical regulator of interleukin-7-dependent CD8+ T cell differentiation. Immunity 18, 475–487 (2003).
  Article CAS Google Scholar
• Cornish, A.L. et al. Suppressor of cytokine signaling-1 has IFN-independent actions in T cell homeostasis J. Immunol. 170, 878–886 (2003).
  Article CAS Google Scholar
• Lewis, D.B. et al. Interleukin 4 expressed in situ selectively alters thymocyte development. J. Exp. Med. 173, 89–100 (1991).
  Article CAS Google Scholar
• McHugh, R.S. et al. CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16, 311–323 (2002).
  Article CAS Google Scholar
• Naka, T. et al. Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases. Int. Immunol. (in the press).
• Pasare, C. & Medzhitov, R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299, 1033–1036 (2003).
  Article CAS Google Scholar
• Fujimoto, M. et al. A regulatory role for suppressor of cytokine signaling-1 in Th polarization in vivo. Int. Immunol. 14, 1343–1350 (2002).
  Article CAS Google Scholar
• Egan, P.J., Lawlor, K.E., Alexander, W.S. & Wicks, I.P. Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation. J. Clin. Invest. 111, 915–924 (2003).
  Article CAS Google Scholar
• Egwuagu, C.E. et al. Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance. J. Immunol. 168, 3181–3187 (2002).
  Article CAS Google Scholar
• Roberts, A.W. et al. Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3. Proc. Natl. Acad. Sci. USA 98, 9324–9329 (2003).
  Article Google Scholar
• Takahashi, Y. et al. SOCS3: an essential regulator of LIF receptor signaling in trophoblast giant cell differentiation. EMBO J. 22, 372–384 (2003).
  Article CAS Google Scholar
• Seki, Y. et al. SOCS-3 regulates onset and maintenance of TH2-mediated allergic responses Nat. Med. 9, 1047–1054 (2003).
  Article CAS Google Scholar
• Cohney, S.J. et al. SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation. Mol. Cell Biol. 19, 4980–4988 (1999).
  Article CAS Google Scholar
• Banerjee, A., Banks, A.S., Nawijn, M.C., Chen, X.P. & Rothman, P.B. Cutting edge: Suppressor of cytokine signaling 3 inhibits activation of NFATp. J. Immunol. 168, 4277–4281 (2002).
  Article CAS Google Scholar
• Matsumoto, A. et al. A role of suppressor of cytokine signaling 3 (SOCS3/CIS3/SSI3) in CD28-mediated interleukin 2 production. J. Exp. Med. 197, 425–436 (2003).
  Article CAS Google Scholar
• Crepso, A., Filla, M.B., Russell, S.W. & Murphy, W.J. Indirect induction of suppressor of cytokine signaling-1 in macrophages stimulated with bacterial lipopolysaccharide: partial role of autocrine/paracrine interferon-α/β. Biochem. J. 349, 99–104 (2000).
  Article Google Scholar
• Bode, J.G. et al. LPS and TNFalpha induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages. LPS and TNFα induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages. FEBS Lett. 463, 365–370 (1999).
  Article CAS Google Scholar
• Dalpke, A.H., Opper, S., Zimmermann, S. & Heeg, K. Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs. J. Immunol. 166, 7082–7089 (2001).
  Article CAS Google Scholar
• Takeda, K. et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10, 39–49 (1999).
  Article CAS Google Scholar
• Yasukawa, H. et al. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat. Immunol. 4, 551–556 (2003).
  Article CAS Google Scholar
• Cheng, F. et al. A critical role for Stat3 signaling in immune tolerance. Immunity 19, 425–436 (2003).
  Article CAS Google Scholar
• Lang, R. et al. SOCS3 regulates the plasticity of gp130 signaling. Nat. Immunol. 4, 546–550 (2003).
  Article CAS Google Scholar
• Croker, B.A. et al. SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 4, 540–555 (2003).
  Article CAS Google Scholar
• Brod, S.A. Ingested type I interferon: a potential treatment for autoimmunity. J. Interferon Cytokine Res. 22, 1153–11566 (2002).
  Article CAS Google Scholar
• Atsumi, T. et al. A point mutation of Tyr-759 in interleukin 6 family cytokine receptor subunit gp130 causes autoimmune arthritis. J. Exp. Med. 196, 979–990 (2002).
  Article CAS Google Scholar
• Tebbutt, N.C. et al. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat. Med. 8, 1089–1097 (2002).
  Article CAS Google Scholar
• Suzuki, A. et al. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J. Exp. Med. 193, 471–481 (2001).
  Article CAS Google Scholar
• Shouda, T. et al. Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J. Clin. Invest. 108, 1781–1788 (2001).
  Article CAS Google Scholar
• Matsumoto, A. et al. Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice. Mol. Cell Biol. 19, 6396–6407 (1999).
  Article CAS Google Scholar
• Li, S. et al. Cytokine-induced Src-homology 2 protein (CIS) promotes T-cell receptor-mediated proliferation and prolongs survival of activated T cells. J. Exp. Med. 191, 985–994 (2000).
  Article CAS Google Scholar
• Krebs, D.L. et al. SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation. Mol. Cell Biol. 22, 4567–4578 (2002).
  Article CAS Google Scholar